Karen Stephenson
Nurse Practitioner · Vero Beach, FLNPI 1669657078
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,630 and has fallen 81.9% since, to $476 in 2025. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 198 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$520
- AstraZeneca$408
- Pharmacyclics LLC, An Abbvie Company$281
- Gilead$215
- AbbVie$198
- Pfizer$195
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,03995%
- Education$2005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 34 | $520 |
| AstraZeneca | 16 | $408 |
| Pharmacyclics LLC, An Abbvie Company | 14 | $281 |
| Gilead(2 entities) | 5 | $215 |
| AbbVie | 6 | $198 |
| Pfizer | 10 | $195 |
| Sirtex Medical Inc | 1 | $165 |
| Merck | 8 | $164 |
| Sanofi | 8 | $156 |
| Daiichi Sankyo Inc. | 6 | $148 |
| Genentech USA, Inc. | 8 | $147 |
| Amgen | 9 | $137 |
| Bristol Myers Squibb | 7 | $136 |
| Blueprint Medicines Corporation | 1 | $129 |
| GSK | 6 | $114 |
| EMD Serono, Inc. | 7 | $112 |
| Incyte Corporation | 5 | $103 |
| Exelixis Inc. | 6 | $101 |
| Bayer | 5 | $95 |
| Array Biopharma Inc | 4 | $79 |
| Beigene USA, Inc. | 4 | $79 |
| Novartis | 3 | $64 |
| Seagen Inc. | 3 | $55 |
| Myriad Genetic Laboratories, Inc. | 2 | $43 |
| Epizyme, Inc. | 2 | $40 |
| Kyowa Kirin, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Tersera Therapeutics LLC | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| Eisai Inc. | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Sobi, Inc | 1 | $20 |
| Dova Pharmaceuticals | 1 | $19 |
| Morphosys, US Inc. | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $16 |
| Novocure Inc. | 1 | $15 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIR-Spheres Microspheres$165
- GAVRETO$129
- Epclusa$116
How this compares
$4,239 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Vero Beach
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.